In alignment with our analysis on patient biopsies, measurement of EHD2 mRNA transcripts revealed that the majority (72%) of cell lines derived from triple negative basal-like breast cancers had low EHD2 mrna expression compared to non-cancer epithelial cell lines (Fig. 2a). This evidence concerns the gene EHD2 and breast carcinoma.